Bruna Velosa Ferreira/LinkedIn
Jun 17, 2026, 14:54
Bruna Velosa Ferreira: PV and ET – Beyond Blood Count Control
Bruna Velosa Ferreira, Hematologist at the Champalimaud Clinical Center, shared a post on LinkedIn:
“PV and ET: Beyond Blood Count Control
Three themes that repeatedly emerged across the MPN sessions at EHA2026:
- Disease modification in PV and ET.
- Markers of biological disease activity beyond conventional risk stratification.
- Emerging therapeutic approaches targeting different aspects of MPN biology, including iron metabolism and mutant CALR.
These are exciting developments for the field, and it will be fascinating to follow how these concepts evolve in the coming years.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering